Experimental evidence underscores the critical role of Nrf2: Nrf2-deficient mice exhibit accelerated retinal degeneration, whereas the pharmacological activation of Nrf2—through the use of compounds such as sulforaphane—reduces oxidative injury and preserves retinal integrity, suggesting therapeutic potential for AMD [14]. The gene discussed is NFE2L2; the disease is retinal degeneration.